Dividend Assets Capital, LLC Novo Nordisk A S Transaction History

Dividend Assets Capital, LLC

$519 Million
Q3 2024

A detailed history of Dividend Assets Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Dividend Assets Capital, LLC holds 208,220 shares of NVO stock, worth $21.5 Million. This represents 4.78% of its overall portfolio holdings.

Number of Shares

208,220

Previous 205,819 1.17%

Holding current value

$21.5 Million

Previous $29.4 Million 15.61%

% of portfolio

4.78%

Previous 6.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $285,887 - $349,153	2,401 Added 1.17%	208,220 $24.8 Million
Q2 2024 Aug 02, 2024	BUY	$122.71 - $146.91 $353,036 - $422,660	2,877 Added 1.42%	205,819 $29.4 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $690,569 - $919,226	6,763 Added 3.45%	202,942 $26.1 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $1 Million - $1.21 Million	-11,443 Reduced 5.51%	196,179 $20.3 Million
Q3 2023 Oct 26, 2023	BUY	$90.94 - $199.54 $8.85 Million - $19.4 Million	97,313 Added 88.22%	207,622 $18.9 Million
Q2 2023 Jul 31, 2023	SELL	$155.98 - $172.65 $1.68 Million - $1.86 Million	-10,750 Reduced 8.88%	110,309 $17.9 Million
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $194,434 - $256,585	-1,896 Reduced 1.54%	121,059 $16.4 Million
Q3 2022 Oct 18, 2022	SELL	$95.28 - $116.93 $41,827 - $51,332	-439 Reduced 0.36%	122,955 $12.3 Million
Q2 2022 Jul 15, 2022	SELL	$103.24 - $121.81 $540,048 - $637,188	-5,231 Reduced 4.07%	123,394 $13.8 Million
Q1 2022 Apr 12, 2022	SELL	$93.1 - $112.54 $495,757 - $599,275	-5,325 Reduced 3.98%	128,625 $14.3 Million
Q4 2021 Feb 23, 2022	SELL	$95.88 - $117.08 $40,749 - $49,759	-425 Reduced 0.32%	133,950 $15 Million
Q3 2021 Nov 01, 2021	SELL	$84.42 - $106.62 $267,695 - $338,092	-3,171 Reduced 2.31%	134,375 $12.9 Million
Q2 2021 Jul 23, 2021	SELL	$67.66 - $84.76 $627,546 - $786,149	-9,275 Reduced 6.32%	137,546 $11.5 Million
Q1 2021 Apr 28, 2021	SELL	$67.06 - $75.82 $33,530 - $37,910	-500 Reduced 0.34%	146,821 $9.9 Million
Q4 2020 Jan 22, 2021	SELL	$63.89 - $73.8 $488,694 - $564,496	-7,649 Reduced 4.94%	147,321 $10.3 Million
Q3 2020 Oct 19, 2020	SELL	$63.69 - $70.22 $221,004 - $243,663	-3,470 Reduced 2.19%	154,970 $10.8 Million
Q2 2020 Aug 03, 2020	SELL	$58.54 - $67.94 $451,987 - $524,564	-7,721 Reduced 4.65%	158,440 $10.4 Million
Q1 2020 May 12, 2020	SELL	$49.46 - $64.78 $227,862 - $298,441	-4,607 Reduced 2.7%	166,161 $10 Million
Q4 2019 Feb 10, 2020	SELL	$49.86 - $58.26 $1.45 Million - $1.7 Million	-29,107 Reduced 14.56%	170,768 $9.88 Million
Q3 2019 Oct 25, 2019	SELL	$47.54 - $53.43 $44,687 - $50,224	-940 Reduced 0.47%	199,875 $10.3 Million
Q2 2019 Jul 12, 2019	SELL	$46.79 - $52.47 $105,698 - $118,529	-2,259 Reduced 1.11%	200,815 $10.3 Million
Q1 2019 May 02, 2019	SELL	$46.36 - $52.63 $923,815 - $1.05 Million	-19,927 Reduced 8.94%	203,074 $10.6 Million
Q4 2018 Feb 07, 2019	SELL	$41.54 - $47.25 $478,956 - $544,792	-11,530 Reduced 4.92%	223,001 $10.3 Million
Q3 2018 Nov 05, 2018	SELL	$46.76 - $51.24 $159,965 - $175,292	-3,421 Reduced 1.44%	234,531 $11.1 Million
Q2 2018 Aug 03, 2018	SELL	$44.29 - $50.42 $800,408 - $911,190	-18,072 Reduced 7.06%	237,952 $11 Million
Q1 2018 May 02, 2018	SELL	$48.49 - $58.14 $12 Million - $14.4 Million	-247,034 Reduced 49.11%	256,024 $12.6 Million
Q4 2017 Jan 31, 2018	SELL	$47.53 - $53.73 $8.9 Million - $10.1 Million	-187,330 Reduced 27.13%	503,058 $27 Million
Q3 2017 Nov 06, 2017	BUY	$41.15 - $49.22 $28.4 Million - $34 Million	690,388	690,388 $33.2 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $233B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dividend Assets Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dividend Assets Capital, LLC with notifications on news.

Account

Dividend Assets Capital, LLC Novo Nordisk A S Transaction History